Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
6-K
Dividend Distribution
confidence 75%
filed 2026-07-23
Shinhan Financial Group's board resolved on July 23, 2026 to cancel 6,698,565 common shares (approximately KRW 700 billion in value) acquired as treasury shares. While technically a share cancellation under Korean Commercial Code Article 343, this action constitutes a return of capital to shareholders by reducing the share count and outstanding equity, functionally equivalent to a dividend or capital distribution. The materiality and scale (KRW 700 billion) make this a material capital allocation event affecting shareholder value.
View raw filing on EDGAR →
6-K
Debt Issuance
confidence 92%
filed 2026-07-23
Shinhan Financial Group's board resolved on July 23, 2026 to issue KRW 270 billion in Write-down Contingent Capital Securities (Basel 3 Compliant Additional Tier 1 Capital). This is a creation of a new direct financial obligation — a debt-like capital instrument with perpetual maturity, call provisions, and a write-down trigger mechanism. The issuance is material to investors as it affects the registrant's capital structure and financial obligations.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-23
Item 2.02
MarineMax issued a press release on July 23, 2026 announcing its fiscal 2026 third quarter results ended June 30, 2026, disclosing revenue of $611.3 million, gross margin expansion of 530 basis points to 35.7%, net income of $15.4 million ($0.66 per diluted share), and reaffirmed fiscal 2026 guidance of $110-125 million Adjusted EBITDA. This is a standard quarterly earnings release with detailed financial statements and management commentary, clearly falling under Item 2.02 disclosure of results of operations and financial condition.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-23
Item 2.02
United Bankshares announced record earnings for Q2 2026 of $131.4 million ($0.95 per diluted share) and first-half 2026 results of $255.6 million ($1.83 per diluted share), with detailed financial metrics including net interest income, provision for credit losses, noninterest income/expense, and tax rates. The press release is furnished under Item 2.02 and attached as Exhibit 99.1, which is the standard format for quarterly earnings disclosures.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-07-23
Item 7.01
This Item 7.01 disclosure concerns a pending merger transaction between LivePerson and SoundHound AI. The filing includes a shareholder letter encouraging a vote "FOR" the transaction at a special meeting scheduled for August 20, 2026, along with a microsite and shareholder FAQ. The letter explicitly discusses the merger benefits, the board's strategic review of alternatives, and the transaction terms (including a 22% premium and debt restructuring). This is a material acquisition activity disclosure—the principal event is the pending merger transaction and shareholder solicitation materials related to it.
View raw filing on EDGAR →
8-K
Exec departure
confidence 75%
filed 2026-07-23
Item 5.02
Javier D. Ferrer announced his retirement as President and Chief Executive Officer effective August 31, 2026, after serving in that role since July 2025. The filing details his retirement benefits and consulting arrangement.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-23
Item 7.01
Jorge J. García was appointed President and Chief Executive Officer effective September 1, 2026, succeeding retiring CEO Javier D. Ferrer. Concurrently, Lidio V. Soriano was appointed Executive Vice President and Chief Financial Officer, and Luis F. Sousa was appointed Executive Vice President and Chief Risk Officer.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-23
Item 2.02
Item 2.02 discloses Acme United's quarterly financial results for Q2 2026 via a press release attached as Exhibit 99.1. The press release reports net sales of $62.7 million (16% increase YoY), net income of $5.1 million (6% increase), and diluted EPS of $1.22 (5% increase), along with detailed segment performance and balance sheet data. This is a standard earnings release disclosure material to investors assessing the company's financial performance.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 95%
filed 2026-07-23
Item 8.01
Popular, Inc. announced an increase in its quarterly common stock dividend from $0.75 to $0.90 per share, commencing in Q4 2026, along with a new $1 billion share repurchase authorization. The primary disclosed action is the dividend increase and capital return program, which materially affects shareholder value and the corporation's capital allocation strategy. While the filing also mentions a share repurchase program, the dividend increase is the principal capital action announced and would affect a reasonable investor's assessment of the company's capital management and shareholder returns.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-23
Item 2.02
Norfolk Southern disclosed its second quarter 2026 financial results on July 23, 2026, reporting record quarterly revenues of $3.5 billion, income from railway operations of $1.1 billion, operating ratio of 67.6%, and diluted EPS of $3.26.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-07-23
Item 7.01
The disclosure announces FDA Orphan Drug Designation (ODD) for IKT-001 in PAH treatment. This is a regulatory milestone that provides development incentives (tax credits, fee exemptions, seven-year market exclusivity) and reflects progress in the company's lead product development. While not a specific named event type, this is clearly an operational/regulatory milestone material to a clinical-stage biotech company's prospects, warranting classification as operational_other rather than other_material since the domain (operational/regulatory) is clear.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-07-23
Item 8.01
Truist Financial Corporation issued and sold $1.25 billion in aggregate principal amount of 4.957% Fixed-to-Floating Rate Medium-Term Notes due July 23, 2030. This is a material creation of a direct financial obligation through debt issuance, disclosed under Item 8.01 (Other Events) and registered under Form S-3. The size and nature of the transaction clearly constitute a material debt issuance event.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-07-23
Item 5.07
This is a clear disclosure of shareholder voting results from the 2026 Annual Meeting of Stockholders held on July 22, 2026. The filing reports the voting outcomes for three proposals: election of seven directors, advisory approval of named executive officer compensation, and ratification of Crowe LLP as independent auditor. The detailed vote tallies (For, Against, Abstain, Broker Non-votes) for each proposal are the core content of Item 5.07, which is the standard Item for reporting shareholder meeting results.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-07-23
Item 1.01
Axalta and AkzoNobel amended their merger agreement (Amendment No. 2, dated July 23, 2026) to modify governance arrangements for the combined company, including shortening director re-election timing from five years to three years and adjusting approval thresholds for key governance matters.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-07-23
Item 2.03
The filing discloses the creation of direct financial obligations through the issuance of consolidated obligation bonds and discount notes by the Federal Home Loan Bank of Pittsburgh. Schedule A itemizes specific debt securities issued on trade dates in July 2026, including bonds with maturities ranging from 2027 to 2046 and principal amounts totaling approximately $280 million. This is a classic debt issuance disclosure under Item 2.03, material to investors assessing the registrant's capital structure and financial obligations.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-23
Item 2.02
Pool Corporation issued a press release on July 23, 2026 reporting second quarter 2026 financial results, including net sales of $1.8 billion (up 2%), operating income of $267.7 million (down 2%), and diluted EPS of $5.17, along with full-year 2026 earnings guidance of $10.66–$10.96 per diluted share (or $10.87–$11.17 excluding CEO transition costs).
View raw filing on EDGAR →
6-K
Dividend Distribution
confidence 72%
filed 2026-07-23
EX-99.1
BCE announced the conversion of all floating-rate Series AJ Preferred Shares into fixed-rate Series AI Preferred Shares on August 4, 2026, with the Series AI shares paying a fixed quarterly dividend at an annual rate of 5.10%. While the primary event is a preferred share conversion (a capital structure adjustment), the disclosure emphasizes the dividend terms and payment obligations that will flow from the converted shares, making this a distribution-related disclosure material to preferred shareholders and investors assessing the company's capital structure and cash obligations.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-07-23
Item 1.01
NALL II and NMAC entered into an Underwriting Agreement on July 21, 2026, for the issuance and sale of notes totaling $1,289,740,000 across multiple classes (A-1 through C) by Nissan Auto Lease Trust 2026-B. This is a material creation of direct financial obligations through a securitized debt offering registered under the Securities Act of 1933, with anticipated closing on July 29, 2026.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 85%
filed 2026-07-23
Item 8.01
The filing discloses the issuance of multiple classes of Asset Backed Notes (Class A-1 through Class C) by Nissan Auto Lease Trust 2026-B, backed by a pool of Nissan and Infiniti leases. This constitutes creation of new direct financial obligations through debt issuance, which is the hallmark of a debt_issuance event. The 8-K is filed to satisfy an undertaking to file legality and tax opinions at the time of takedown from the Registration Statement, confirming the debt offering has occurred.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-23
Item 2.02
Princeton Bancorp issued a press release on July 23, 2026, disclosing unaudited financial condition and results of operations for the quarter and six months ended June 30, 2026. The filing reports net income of $7.1 million ($1.04 per diluted share) for Q2 2026, detailed balance sheet changes, and comprehensive financial metrics including net interest income, non-interest expense, and asset quality. This is a standard quarterly earnings release with accompanying financial statements attached as Exhibit 99.1, typical of Item 2.02 disclosures.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-07-23
Item 2.02
The filing announces the scheduling of an earnings release for Q2 2026 (to be released August 10, 2026) and a corresponding investor conference call (August 11, 2026). While the actual financial results are not yet disclosed in this 8-K, the announcement of the earnings release date and call is a standard earnings_release disclosure under Item 2.02, and the attached press release explicitly states "Bain Capital Specialty Finance, Inc. Schedules Earnings Release for the Second Quarter Ended June 30, 2026."
View raw filing on EDGAR →
8-K
Earnings release
confidence 97%
filed 2026-07-23
Item 2.02
Financial Institutions, Inc. issued a press release on July 23, 2026 reporting Q2 2026 financial results, including net income of $20.8 million ($1.04 per diluted share), loan growth of 2.7%, and assets under management of $4.0 billion, with comprehensive balance sheet and income statement data.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-07-23
EX-99.1
This exhibit is a press release announcing MindWalk's first public demonstration of ReefIQ™, its biological context layer for AI drug discovery, at AMD Advancing AI 2026. The disclosure highlights a significant product milestone and market engagement activity—unveiling a core technology platform to life-sciences customers and infrastructure partners. While not a discrete M&A transaction, earnings release, or executive change, the public launch of a flagship product and the stated business development engagement with customers and partners constitute a material operational/strategic event that would affect a reasonable investor's assessment of the company's market positioning and commercial progress.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-07-23
Item 3.02
Apollo Debt Solutions BDC sold 186,709 unregistered Class I Common Shares for $4,449,521 to feeder vehicles, relying on Section 4(a)(2) and Regulation S exemptions from Securities Act registration. This capital raise represents a significant equity dilution event for existing shareholders.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 95%
filed 2026-07-23
Item 7.01
Apollo Debt Solutions BDC declared distributions for each class of common shares on July 23, 2026, at $0.1800 gross per share (with varying net amounts after fees), payable to shareholders of record as of July 31, 2026, and to be paid on or around August 28, 2026, either in cash or through the Fund's distribution reinvestment plan.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-23
Item 2.02
SS&C Technologies announced its Q2 2026 financial results on July 23, 2026, disclosing GAAP revenue of $1,695.7 million (up 10.3%), diluted EPS of $0.97 (up 34.7%), and adjusted diluted EPS of $1.76 (up 18.1%). The press release and earnings presentation are furnished as Exhibits 99.1 and 99.2, which is the standard format for earnings releases under Item 2.02. The disclosure includes detailed financial statements, guidance, and management commentary on operational performance.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-23
Item 5.02
Jeffrey Rowe was appointed as Executive Vice President and Chief Operating Officer of ADM, effective August 17, 2026, in a newly created role overseeing commercial businesses, global manufacturing, and R&D. Rowe brings 30+ years of industry experience, including prior service as CEO of Syngenta Group, and will report directly to the CEO.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-07-23
Item 8.01
Southern California Edison Company and SCE Recovery Funding LLC entered into an Underwriting Agreement on July 21, 2026 for the issuance of $1,953,948,000 of Senior Secured Recovery Bonds, Series 2026-A. This constitutes creation of a new direct financial obligation through debt issuance, a material event affecting the registrant's capital structure and financial position.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 98%
filed 2026-07-23
Item 8.01
State Street Bank, a wholly-owned subsidiary of State Street Corporation, issued $1.25 billion in aggregate principal amount of senior notes ($750 million due 2029 at 4.701% and $500 million due 2034 at 5.217%) on July 23, 2026. This is a clear creation of a new direct financial obligation through debt issuance, with net proceeds of approximately $1.244 billion. The disclosure includes the fiscal agency agreement and purchase agreement details, all hallmarks of a material debt issuance event.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-23
Item 2.02
Item 2.02 discloses Byline Bancorp's second quarter 2026 financial results via a press release (Exhibit 99.1) announcing net income of $40.2 million and diluted EPS of $0.90, along with detailed financial statements and performance metrics. This is a standard quarterly earnings release, the primary disclosure type for Item 2.02.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 98%
filed 2026-07-23
Item 8.01
JPMorgan Chase closed public offerings of $9 billion in aggregate principal amount of debt securities, including Floating Rate Notes, Fixed-to-Floating Rate Notes, and Subordinated Notes due 2030-2041. This constitutes creation of new direct financial obligations and is a material debt issuance event requiring 8-K disclosure under Item 2.03 (though filed under Item 8.01).
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-07-23
Item 8.01
SBA Communications issued $3.5 billion in aggregate principal amount of senior notes across three tranches (2030, 2031, and 2033 maturities) that closed on July 23, 2026. This is a material creation of direct financial obligations disclosed under Item 8.01, representing a significant debt issuance that would affect investor assessment of the company's capital structure and financial position.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-23
Item 2.02
Enova issued a press release on July 23, 2026 announcing consolidated financial results for Q2 2026 (three months ended June 30, 2026), disclosing revenue of $929 million (up 22% YoY), net income of $105 million ($4.00 diluted EPS, up 38% YoY), and adjusted EPS of $4.31 (up 33% YoY). The press release is furnished as Exhibit 99.1 and filed under Item 2.02, which is the standard Item for earnings releases. This is a material quarterly earnings disclosure that would affect a reasonable investor's assessment of the company's financial performance and prospects.
View raw filing on EDGAR →
8-K
Earnings release
confidence 92%
filed 2026-07-23
Item 2.02
Codexis disclosed preliminary quarterly financial results for Q2 2026, including total revenue of at least $14.8 million and cash/equivalents of approximately $54.9 million as of June 30, 2026.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-23
Item 5.02
ImageneBio appointed Yanina Grant-Huerta as Chief Financial Officer, principal financial officer, and principal accounting officer effective July 20, 2026, with a base salary of $450,000, 40% bonus eligibility, RSU and option grants, and severance benefits.
View raw filing on EDGAR →
8-K
Exec departure
confidence 85%
filed 2026-07-23
Item 8.01
Benjamin Porter-Brown, Chief Medical Officer, transitioned from his full-time executive position to a consulting role effective July 24, 2026.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-23
Item 2.02
Boston Beer disclosed second quarter 2026 financial results on July 23, 2026, via an earnings release attached as Exhibit 99. The disclosure includes detailed quarterly and year-to-date revenue, gross margin, earnings per share, and full-year 2026 guidance. This is a standard quarterly earnings release under Item 2.02 (Results of Operations and Financial Condition), which is material to investors assessing the company's financial performance and outlook.
View raw filing on EDGAR →
8-K
Earnings release
confidence 75%
filed 2026-07-23
Item 2.02
First Eagle Private Credit Fund disclosed its results of operations and financial condition as of June 30, 2026, including Net Asset Value per share of $23.79 for both Class I and Class D shares, portfolio fair value of $552.9 million, and weighted average yield of 9.53%.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 95%
filed 2026-07-23
Item 7.01
First Eagle Private Credit Fund declared regular distributions to shareholders with per-share amounts of $0.210 for Class I shares and $0.205 net for Class D shares, with a record date of July 31, 2026 and payment date of August 28, 2026.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-07-23
Item 2.02
The filing discloses a press release announcing a conference call to discuss the Partnership's Second Quarter 2026 results. Although the actual financial results are not yet disclosed in this announcement, the registrant is formally announcing the earnings call and furnishing the press release as Exhibit 99.1 under Item 2.02 (Results of Operations and Financial Condition), which is the standard Item for earnings releases. This is a material disclosure as it signals the timing of financial results disclosure to investors.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-23
Item 2.02
National Bankshares, Inc. issued a press release on July 23, 2026, reporting financial results for the six months and three months ended June 30, 2026. The disclosure includes net income of $10.01 million ($1.57 per diluted share) for the six-month period and $5.03 million ($0.79 per diluted share) for the three-month period, along with detailed balance sheet data, asset composition, and operational metrics. This is a standard quarterly earnings release filed under Item 2.02 and is material to investors assessing the registrant's financial performance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-23
Item 2.02
Virginia National Bankshares Corporation announced consolidated earnings for the three and six months ended June 30, 2026, reporting quarterly net income of $9.0 million ($1.65 per diluted share) versus $4.2 million ($0.78 per diluted share) in the prior year period.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 95%
filed 2026-07-23
Item 8.01
The Board of Directors approved a cash dividend of $0.36 per share payable on August 28, 2026, representing a quarterly dividend with an annualized yield of approximately 3.20%.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-07-23
Item 2.03
ADTRAN entered into a new $350 million senior secured credit facility with JPMorgan Chase Bank as administrative agent on July 21, 2026, refinancing its prior Wells Fargo credit agreement. The facility strengthens the company's capital structure, lowers borrowing costs, and extends maturities.
View raw filing on EDGAR →
6-K
Earnings release
confidence 85%
filed 2026-07-23
EX-99.1
This is a press release announcing Q2 2026 financial and operational results for OwlTing Group's OwlPay Harbor platform, disclosing that processed volume grew more than 5x quarter-over-quarter, reached a record high in July, and cumulative platform volume surpassed US$600 million as of June 30, 2026. The disclosure of quarterly operational metrics and platform performance tied to a specific reporting period (Q2 2026) is characteristic of an earnings or results announcement, material to investors assessing the company's growth trajectory and business performance.
View raw filing on EDGAR →
8-K
Exec departure
confidence 92%
filed 2026-07-23
Item 5.02
Benjamin Adams, Executive Vice President and Chief Legal Officer, notified the Company on July 20, 2026 of his intention to depart effective November 2, 2026, through participation in a Voluntary Retirement Program. While subsection (e) describes compensatory arrangements under the retirement program, the principal disclosed action is the departure of a named executive officer from a senior leadership position overseeing legal, privacy, public policy and enterprise risk functions.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-07-23
Item 1.01
Summit Therapeutics entered into an at-the-market (ATM) distribution agreement with J.P. Morgan Securities to offer and sell up to $380 million in common stock shares. This is a dilutive equity issuance structured as an ATM offering under Rule 415(a)(4), which allows the company to raise capital by selling shares at prevailing market prices. The magnitude ($380M) and structure (unregistered equity sales through a sales agent) are material to investors assessing capital structure and shareholder dilution.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-23
Item 2.02
BancFirst Corporation disclosed its second quarter 2026 financial results on July 23, 2026, reporting net income of $66.7 million ($1.96 per diluted share) versus $62.3 million ($1.85 per diluted share) in Q2 2025. The disclosure includes a comprehensive press release with detailed income statements, balance sheet data, asset quality metrics, and performance ratios—the standard format for quarterly earnings releases filed under Item 2.02. This is a material event affecting investor assessment of the registrant's financial performance and condition.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 75%
filed 2026-07-23
Item 8.01
Bank of New York Mellon entered into an underwriting agreement on July 16, 2026 for a public offering of 500,000 depositary shares representing interests in Series N Noncumulative Perpetual Preferred Stock, creating a material direct financial obligation and capital-raising event that affects the registrant's capital structure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-07-23
Item 5.02
The filing discloses both a director resignation (Adam Malinowski) and an appointment (Gregory Williams to the Board effective July 23, 2026). While both events occur, the principal disclosed action centers on the appointment of Williams to fill the vacancy, with detailed background on his qualifications, experience, and compensation terms. The appointment of a new director to the board is material to investors' assessment of governance and board composition.
View raw filing on EDGAR →